Age-dependent increases in dorsal hippocampal postsynaptic α5GABA-a receptors may be lost in a rat model of Alzheimer’s disease
Open Access
- 28 November 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Targeting amyloid for inhibition of neurodegeneration and cognitive decline in Alzheimer’s Disease (AD) using selective therapeutics has been mildly successful, but an improved understanding of memory dysfunction on a neural circuitry level may be needed for development of acute nootropics for ongoing memory dysfunction. Here, we focus on the hypothesis that if early onset memory decline can be traced to the hippocampal trisynaptic circuit, then it could serve as a target for therapeutic modulation. Inhibitory GABAergic neurons participate in sharp wave ripple (SPW-R) oscillations in the hippocampal trisynaptic circuit as detected in CA1 during sleep and awake inactivity and are believed to function in memory replay and consolidation. Using the transgenic beta amyloid expressing TgF344-AD rat, which develops frank neurodegeneration and memory impairment with age, we previously discovered that ripple amplitude in 9mo and older TgF344-AD rats are insensitive to the nootropic drug α5IA, a negative allosteric modulator of α5-subunit containing γ-aminobutyric acid type A receptors (α5GABAARs). Here, we ask whether the loss of α5IA potentiation of ripple amplitude might reflect AD-specific downregulation of the predominant extrasynaptic α5GABAAR isoform. To our surprise, however, postsynaptic α5GABAAR levels decrease with aging in the dorsal dentate gyrus (DG) of TgF344-AD while increasing in wt littermates. The results support a model wherein age-associated beta-amyloid inhibits α5GABAAR trafficking. We posit that reducing α5GABAAR trafficking in excitatory specifically to the postsynaptic compartment in dorsal DG, and likely in CA1 neurons, may reduce their ability to shape local field potentials, including ripples, and blunt the pharmacological action of α5IA on ripple amplitude.Keywords
Funding Information
- National Institutes of Health, United States (NIGMS T32 GM008541, NIA R21AG056947, NIA R21AF061553-01)
- National Institutes of Health (NIA R21AG056947 NIH/NIA R21AF061553-01)
This publication has 42 references indexed in Scilit:
- Prodromal dysfunction of α5GABA-A receptor modulated hippocampal ripples occurs prior to neurodegeneration in the TgF344-AD rat model of Alzheimer's diseaseHeliyon, 2021
- Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiologyAgeing Research Reviews, 2021
- A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular ResolutionMolecular Neurobiology, 2017
- Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's DiseaseNeurotherapeutics, 2017
- α5GABAAReceptors Mediate Tonic Inhibition in the Spinal Cord Dorsal Horn and Contribute to the Resolution Of HyperalgesiaJournal of Neuroscience Research, 2016
- The hippocampusCurrent Biology, 2015
- Hippocampal sharp wave‐ripple: A cognitive biomarker for episodic memory and planningHippocampus, 2015
- Combined administration of levetiracetam and valproic acid attenuates age-related hyperactivity of CA3 place cells, reduces place field area, and increases spatial information content in aged rat hippocampusHippocampus, 2015
- Alzheimer and his disease: a brief historyNeurological Sciences, 2010
- Synaptic and nonsynaptic localization of GABAAreceptors containing the α5 subunit in the rat brainJournal of Comparative Neurology, 2006